Multi-centre, Randomised, Open-Label, Blinded Endpoint Assessed, Trial of Corticosteroids Plus Intravenous Immunoglobulin (IVIG) and Aspirin, Versus IVIG and Aspirin for Prevention of Coronary Artery Aneurysms (CAA) in Kawasaki Disease (KD): the KD CAA Prevention (KD-CAAP) Trial Protocol
Trials(2023)
关键词
Kawasaki disease,Corticosteroids,Coronary artery aneurysms
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要